• to decrease the potential risk of severe cardiovascular (coronary heart and blood vessel) challenges in Grown ups with type 2 diabetes and cardiovascular diseaseThis led Novo Nordisk to carry out more investigation into higher dosages of semaglutide especially for weight management.They aided us untangle the online of drugmakers and pharmacies